Home / Resources / Late Clinical resources

晚期临床

最新资源

Highlights from the FDA Guidance on Dosage Optimization for Therapeutic Radiopharmaceuticals

Highlights from the FDA Guidance on Dosage Optimization for Therapeutic Radiopharmaceuticals

Dizal Pharma

Certara & Dizal Partner to Fast-Track FDA Approval of Sunvozertinib for Lung Cancer

Certara Launches DIDB® Concomitant Meds Navigator, Extending Leadership in Drug Interaction Science

Certara Launches DIDB® Concomitant Meds Navigator, Extending Leadership in Drug Interaction Science

精选资源

Best Practices in Clinical Pharmacology Gap Analysis

临床药理学差距分析最佳实践

Upcoming late clinical webinars

网络研讨会

The Pursuit of Certainty: Integrated Evidence and the evolving drug development and reimbursement landscape

2025 年 10 月 8 日 – 11 am ET

网络研讨会

临床试验中降低 DDI 管理风险：介绍 DIDB 联合用药导航工具

2025 年 10 月 15 日 – 10 a.m. ET, 4 p.m. CEST

网络研讨会

Quantitative Systems Pharmacology-Based Virtual Twin® Approach for Clinical Development in Rare Diseases

2025 年 10 月 15 日 – 10am ET

Latest late clinical blogs

All Late clinical - blog

回顾创纪录的 2025 Krakow HTA Symposium

CERTAINTY 2025: 模型引导的药物开发的强大力量

药物开发中 PK/PD 建模的机器学习

为何 FDA 批准 omaveloxolone 用于治疗弗里德赖希共济失调症意义重大

2024 年 Pinnacle 21 Enterprise 用户会议上聚焦临床研究软件

Don’t Miss Our Inaugural Event for Biosimulation Users

在以下活动中与我们的专家会面

Phoenix Roadshow 2025 – Copenhagen

2025 年 10 月 7 日

CDISC US 2025

2025 年 10 月 13 - 14 日

ACoP 2025

2025 年 10 月 18 - 21 日

All late clinical resources

Certara & Dizal Partner to Fast-Track FDA Approval of Sunvozertinib for Lung Cancer

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Therapeutic Specialties, Case Study

Certara 大学：Introducing Certara’s Phoenix Cloud TFL Studio: Streamlined Creation of Tables, Figures & Listings

Certara Products - Phoenix, Clinical Pharmacology, Modeling and Simulation - PK/PD, Webinar

临床药理学差距分析最佳实践

Certara Services, Clinical Pharmacology, Modeling and Simulation, Blog

What are the biggest roadblocks still standing in the way of cell and gene therapy commercialization?

Biologics, Cell and Gene Therapy, Certara Services, Therapeutic Specialties, Press Coverage

What is a Loading Dose?

Certara 产品 - Phoenix，建模和模拟 - PK/PD，博客，知识库

Biogen Transforms Study Metadata Management with Certara’s Metadata Repository

Certara Products - Pinnacle 21, Data Standards, Case Study

Large Biotech Streamlines Investigator’s Brochures with Certara’s Project Management Expertise

Certara Services, Clinical Trials, Drug Development, Project Management, Case Study

The Pursuit of Certainty: Integrated Evidence and the evolving drug development and reimbursement landscape

Certara Services, Drug Development, Model Informed Drug Development, Modeling and Simulation, Webinar

Certara IQ™: The Scalable AI-Powered QSP Software

Modeling and Simulation - QSP, Webinar

Accelerate your SDTM Mapping with Pinnacle 21 Enterprise Plus

Certara Products - Pinnacle 21, Data Standards, SDTM, Blog

Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma

Biologics, Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation - PK/PD, Publication

Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2− Metastatic Breast Cancer Data From the Phase 3 TROPiCS‐02 Trial

Biologics, Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation - PK/PD, Therapeutic Specialties, Publication

1
2
3
……
40
›

订阅时事通讯

为什么订阅？因为改变药物开发不仅是我们的目标，更是我们的执着追求。如果这也是您的想法，那么请第一时间了解新见解，与我们一起推动科学发展。

© 2025 Certara. 保留所有权力。 | 法律 | 隐私政策

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software